Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial  (2025-09-17)
Eli Lilly said orforglipron was better at lowering blood sugar levels than Novo Nordisk's oral semaglutide, and helped patients lose more weight.